Medtech Insight featured life sciences partner Michele Buenafe in a detailed Q&A about how device-makers will have to take a more proactive approach to understanding the safety of biomaterials they use for their implanted devices, and how these materials might affect patients during post-market use.
Read the full Medtech Insight* article >>
*subscription may be required